Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B4JL
|
||||
Former ID |
DIB000871
|
||||
Drug Name |
SERAZAPINE HYDROCHLORIDE
|
||||
Synonyms |
CGS-15040A; Serazapine hydrochloride < Rec INNM; Rac-2-Methyl-1,3,4,16b-tetrahydro-2H,10H-indolo[2,1-c]pyrazino[1,2-a][1,4]benzodiazepine-16-carboxylic acid methyl ester monohydrochloride
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Anxiety disorder [ICD9: 300, 311; ICD10:F32, F40-F42] | Discontinued in Phase 2 | [544867] | ||
Structure |
Download2D MOL |
||||
Formula |
C22H24ClN3O2
|
||||
Canonical SMILES |
COC(=O)c1c2C3CN(C)CCN3c4ccccc4Cn2c5ccccc15
|
||||
InChI |
1S/C22H23N3O2/c1-23-11-12-24-17-9-5-3-7-15(17)13-25-18-10-6-4-8-16(18)20(22(26)27-2)21(25)19(24)14-23/h3-10,19H,11-14H2,1-2H3
|
||||
InChIKey |
WPGUWABWNUSPMW-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 117581-05-2
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Antagonist | [526792], [533896] | |
PANTHER Pathway | 5HT2 type receptor mediated signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.